Pietro B Carrieri Selected Research

Biomarkers (Surrogate Marker)

1/2008

Interleukin-10 and interleukin-12 modulation in patients with relapsing-remitting multiple sclerosis on therapy with interferon-beta 1a: differences in responders and non responders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pietro B Carrieri Research Topics

Disease

3	Relapsing-Remitting Multiple Sclerosis 09/2015 - 01/2008
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2015
1	Obesity 09/2015
1	Multiple Sclerosis 09/2015
1	Disease Progression 01/2008

Drug/Important Bio-Agent (IBA)

1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2015
1	LeptinIBA 09/2015
1	CD40 Ligand (CD40L)IBA 09/2015
1	OsteoprotegerinIBA 09/2015
1	Leptin ReceptorsIBA 09/2015
1	Peroxidase (Myeloperoxidase)IBA 09/2015
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 09/2015
1	Glatiramer Acetate (Copaxone)FDA Link 09/2015
1	Interleukin-2 (IL2)IBA 01/2014
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2014
1	Interleukin-10 (Interleukin 10)IBA 01/2008
1	InterferonsIBA 01/2008
1	InterleukinsIBA 01/2008
1	Biomarkers (Surrogate Marker)IBA 01/2008
1	Interferon beta-1a FDA Link 01/2008
1	Interleukin-12 (IL 12)IBA 01/2008

Therapy/Procedure

1	Therapeutics 01/2008